Full text is available at the source.
The interplay between microbiota and the gut-brain axis in treatment-resistant depression
How gut bacteria and gut-to-brain communication relate to treatment-resistant depression
AI simplified
Abstract
Changes in gut microbiota composition may contribute to the development and persistence of treatment-resistant depression (TRD).
- The microbiota-gut-brain axis connects gut microorganisms with the immune system and brain functions.
- Alterations in gut microorganisms can impact neurotransmitter production and blood-brain barrier function.
- Variations in short-chain fatty acid production and immune responses may influence TRD.
- Disruptions in the hypothalamic-pituitary-adrenal axis and neurotransmitter signaling are associated with TRD.
- Potential treatment strategies targeting the gut microbiome include modifications and probiotics.
AI simplified